MRDN

MRDN

MRDNNYSE / NASDAQ

$3.92+$0.16 (+4.3%)

Last close · Data as of Nov 20, 2026

A period is left blank when the price history is shorter than the period.

MRDN price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-63.8%
3M
-72.0%
6M
-63.4%
1Y
Short history
5Y
Short history
  • A period is left blank when the price history is shorter than the period.

52-week range

Day change +$0.16 (+4.3%) from $4 to $4 · Last close Nov 20, 2026

News & filings

What MRDN filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

No rule stands out for this company on the data on file as of 20 Nov 2026.

  • Financial statements for this company are not on file.

Prices to the 20 Nov 2026 close

Rule-based from financial data. Not advice.

About the company

Meridian Holdings Inc., a business-to-business and business-to-consumer gaming technology company, provides casino, sportsbook, and competition products in Central and South America, Europe, and Africa. It develops and licenses gaming platforms; and provides online sports betting and gaming operations under various brands, including Meridianbet, Expanse Studios, MexPlay, R Kings Competitions, Classics For A Cause, and GMAG. Meridian Holdings Inc. is based in Las Vegas, Nevada.

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

52-week high
$14.72
52-week low
$3.76

Growth

No growth data available.

No growth data available.

Monthly returns

Month-by-month returns of MRDN across the years, with the seasonal pattern.

Market cap against peers

8 peers: same sector, nearest by size.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): MRDN, Tvardi Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
MRDNMRDNthis company—————
INmune Bio Inc.INMB$35.9M-0.8x1.5x-195.3%-0.4x
Neonode Inc.NEON$31.0M3.7x1.3x34.4%0.8x
Tvardi Therapeutics, Inc.TVRD$28.9M-1.6x1.4x-87.0%-0.3x
GoHealth, Inc.GOCO$21.4M-0.1x0.6x-678.9%-2.0x
Sleep Number CorporationSNBR$8.1M——22.8%105.2x
zSpace, Inc.ZSPC$959.7k-0.0x-0.0x112.8%-0.8x
Trinseo PLCTSEOF$475.3k-0.0x-0.0x49.7%39.4x
ACCO Brands CorporationACCO$0.000.0x0.0x6.2%5.1x
Peer median—-0.0x0.6x14.5%0.2x

Year-to-date ROI

MRDN since 1 January, against earlier years.

Historical volatility

MRDN's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

No financial statement data available.

Learn while you research

Academy chapters picked for MRDN and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  3. 03 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →